CTN :43492303
30 Jan, 2026
55.94 Crore
Tender For supply of essential drugs under sdl. - colistimethate sodium injection 1 million iu powder for solutionvial, faropenem tablet 200mg 1x6, polymixin b injection 500000 iuvial, tigecycline injection 50mgvial, teicoplanin injection 400mgvial, valganciclovir tablet 450 mg1x2, voriconazole tablet 200 mg 1x4, nicorandil tablet 10 mg1x10/1x20, isoprenaline injection 2mg1 ml amp, octreotide injection 100 mcg/ml1 ml amp, acetylsalicylic acid (a)+clopidogrel(b)tablet (a)150 mg+(b)75 mg1x10, reteplase injection 18 mg vial, rifaximine tablet 550mg1x10, empagliflozin tablet 10 mg1x10, linagliptine tablet 5mg1x10, sitagliptin capsule 50 mg1x7/1x10, recombinant growth hormone injection per iuvial/pfs, ranibizumab injection 10 mg/ml (2.3 mg/0.23 ml per vial)vial/amp, i.v fat emulsion infusion 20%100 ml bottle, human albumin infusion 20%100 ml bottle /bag, multi-electrolyte in 5% dextroseinfusion 500 ml ffs plastic bottle, recombinant factor viia injection 1mgvial, rurioctocog alfa pegol injection 500 iu.vial/pfs, eptacog alfa (class="text-red-selected">activated re
combinant
coagulation fa
ctor viia)
inje
ction 1 mgvial/pfs, luspater
cept
inje
ction 25 mg.vial, deferasirox tablet 400mg1x6/1x10, deferasirox tablet 100mg1x6/1x10, olanzapine tablet 10 mg1x10, quetiapine tablet 50mg1x10, gabapentin
capsule 300 mg1x10, dutasteride soft gelatin
capsule 0.5mg1x10, tamsulosin tablet 0.4mg mr1x10, silodosin tablet 8mg1x10, sevelamer tablet 400 mg 1x10, abiraterone a
ceteatetablet 250 mg120 tablets in a bottle, anti thymo
cyte globuline
inje
ction 250 mg.5 ml glass vial, aza
citidine
inje
ction 100 mgvial,
cisplatin
inje
ction 50mgvial,
crizotinib
capsule 250mg1x10,
cytarabine
inje
ction 100mgvial,
cytarabine
inje
ction 500mgvial, dasatinib tablet 50 mg60 tabs
container, de
citabine
inje
ction 30 mgvial, daratumumab
inje
ction 400 mg/20 ml vial, daratumumab + hyaluronidase
inje
ction 1,800 mg daratumumab and 30,000 units hyaluronidase per 15 ml (sub
cutaneous)single-dose vial., degarelix
inje
ction 80mgvial, enzalutamide
capsule 40 mg 1x28, erlotinib tablet 150mg1x10, everolimus tablet 0.25 mg 1x10, ibrutinib
capsule 140mg120
capsule in a bottle, ifosamide
inje
ction ifosamide 1 gm with mesna 200 mg
combi pa
ck of 20 ml vial of ifosamide & 3x2 ml amps of mesna, ea
ch 2 ml amp
contains 200 mg mesna., leu
covorin
inje
ction 50mg/5 mlvial/ampoule, leuprolide
inje
ction 3.75mgvial, nilotinib tablet/
capsule 150 mg1x7/1x14, nilotinib tablet/
capsule 200mg1x7/1x14, pa
clitexal
inje
ction 260 mgvial, palbo
ci
clib tablet/
capsule 75 mg1x7/1x21, palbo
ci
clib tablet/
capsule 125 mg1x7/1x21, pazopanib tablet 400mg30 tablets in a bottle, ribo
ci
clib tablet 200 mg1x21, ruxolitinibtablet 20 mg1x10/1x14, sorafinibtab 200mg120 tablets in a bottle, sunitinib tablet/
capsule 12.5mg1x7, beva
cizumab
inje
ction 100mgvial, onasemnogene abeparvove
c suspension for iv infusion 2.0 1013 ve
ctor genomes/mlvial, as
ciminib tablet 40 mg.30 tablets in a bottle, mepolizumab
inje
ction 100 mg vial, te
clistamab
inje
ction 30 mg/3ml (10 mg/ml)vial, obinutuzumab
inje
ction 1,000 mg/40 ml (25 mg/ml) vial, polatuzumab vedotin
inje
ction 140 mg/vial.vial, atezolizumab
inje
ction 1,200 mg/20 ml (60 mg/ml) vial, spesolimab
inje
ction 450 mg/7.5 ml (60 mg/ml) vial, pembrolizumab
inje
ction 100 mg/4 ml (25 mg/ml)vial, o
crelizumab
inje
ction 300 mg/10 mlvial, ustekinumab
inje
ction 130 mg/26 ml (5 mg/ml)vial, benralizumab
inje
ction 30 mg/1 mlpfs, fari
cimab
inje
ction 6 mg/0.05 ml (120 mg/ml)vial, a
calabrutinib
capsule 100 mg30
capsule in a bottle, inotuzumab ozogami
cin
inje
ction 1 mg/vialvial, buprenorphine (a) + naloxone (b)tablet (sub-lingual) 2 mg (a) + 0.5 mg (b)1x10, etaner
cept
inje
ction 25 mgpfs/vial, etaner
cept
inje
ction 50 mgpfs/vial, aliro
cumab
inje
ction 75 mg/ml.pfs, evolo
cumab
inje
ction 140 mg/ml.pfs, in
clisiran
inje
ction 284 mg/1.5 ml.pfs, risdiplam tablet 5 mg30 tablets in a bottle, risdiplam powder for oral solution 0.75 mg/ml after re
constitution.80 ml bottle, fulvestrant
inje
ction 250 mgvial/pfs, re
combinant human interferon beta-1a
inje
ction 30 m
cg